Essential oil of Thujopsis dolobrata suppresses atopic dermatitis- like skin lesions in NC/Nga mice

Biomolecules and Therapeutics

Volumn 19, Issue 1, 2011, Pages 102-108

  Nam, Kung Woo ^a,d   Noh, Jae Kyu ^a   Kim, Su Kwan ^b   Lee, Sung Jin ^c   Kim, Kyeong Ho ^c   Oh, Ki bong ^a   Shin, Jongheon ^a   Mar, Woongchon ^a  

^a Seoul National University   (South Korea)

^b G and G Co Ltd   (South Korea)

^c Kangwon National University   (South Korea)

^d Korea University College of Medicine   (South Korea)

Author keywords

Atopic dermatitis; Beta hexosaminidase; IgE; NC Nga mouse; Thujopsis dolobrata

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; BETA N ACETYLHEXOSAMINIDASE; BETAMETHASONE; ESSENTIAL OIL; HISTAMINE; HYDROCORTISONE; IMMUNOGLOBULIN E; KETOTIFEN; PLANT EXTRACT; THUJOPSIS DOLOBRATA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CELL INFILTRATION; CONTROLLED STUDY; CUPRESSACEAE; DEGRANULATION; DRUG STRUCTURE; HISTAMINE METABOLISM; IMMUNOGLOBULIN PRODUCTION; INHIBITION KINETICS; LEUKEMIA CELL; MALE; MAST CELL; MOUSE; NONHUMAN; RAT; SCORING SYSTEM; THUJOPSIS DOLOBRATA;

CUPRESSACEAE; MUS; RATTUS; THUJOPSIS DOLABRATA;

EID: 79851487349     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2011.19.1.102     Document Type: Article

References (27)

1. Alenius, H., Laouini, D., Woodward, A., Mizoguchi, E., Bhan, A. K., Castigli, E., Oettgen, H. C. and Geha, R. S. (2002) Mast cells regulate IFN-gamma expression in the skin and circulating IgE levels in allergen-induced skin infl ammation. J. Allergy Clin. Immunol. 109, 106-113.
2. Amon, U., Dieckmann, D., Nitschke, M., Wehrhahn, C. and Wolff, H. H. (1995) The role of basophilic leukocytes in infl ammatory skin diseases. Hautarzt 46, 234-239.
3. Barker, J. N., Palmer, C. N., Zhao, Y., Liao, H., Hull, P. R., Lee, S. P., Allen, M. H., Meggitt, S. J., Reynolds, N. J., Trembath, R. C. and McLean, W. H. (2007) Null mutations in the fi laggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J. Invest. Dermatol. 127, 564-567.
4. Brenninkmeijer, E. E., Legierse, C. M., Sillevis Smitt, J. H., Last, B. F., Grootenhuis, M. A. and Bos, J. D. (2009) The course of life of patients with childhood atopic dermatitis. Pediatr. Dermatol. 26, 14-22.
5. Chen, L., Lin, S. X., Overbergh, L., Mathieu, C. and Chan, L. S. (2005) The disease progression in the keratin 14 IL-4-transgenic mouse model of atopic dermatitis parallels the up-regulation of B cell activation molecules, proliferation and surface and serum IgE. Clin. Exp. Immunol. 142, 21-30.
6. Chen, L., Overbergh, L., Mathieu, C. and Chan, L. S. (2008) The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model. Clin. Exp. Allergy 38, 1367-1380.
7. Choi, J. J., Park, B., Kim, D. H., Pyo, M. Y., Choi, S., Son, M. and Jin, M. (2008) Blockade of atopic dermatitis-like skin lesions by DA-9102, a natural medicine isolated from Actinidia arguta, in the Mg-defi ciency induced dermatitis model of hairless rats. Exp. Biol. Med.(Maywood) 233, 1026-1034.
8. Elias, P. M. (2008) Barrier repair trumps immunology in the pathogenesis and therapy of atopic dermatitis. Drug Discov. Today Dis. Mech. 5, e33-e38.
9. Ference, J. D. and Last, A. R. (2009) Choosing topical corticosteroids. Am. Fam. Physician. 79, 135-140.
10. Fischer, M., Harvima, I. T., Carvalho, R. F., Möller, C., Naukkarinen, A., Enblad, G. and Nilsson, G. (2006) Mast cell CD30 ligand is upregulated in cutaneous infl ammation and mediates degranulationindependent chemokine secretion. J. Clin. Invest. 116, 2748-2756.
11. Kawakami, T., Ando, T., Kimura, M., Wilson, B. S. and Kawakami, Y. (2009) Mast cells in atopic dermatitis. Curr. Opin. Immunol. 21, 666-678.
12. Leung, D. Y. (1995) Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J. Allergy Clin. Immunol. 96, 302-318.
13. Leung, D. Y. and Bieber, T. (2003) Atopic dermatitis. Lancet 361, 151-160.
14. Levin, C. and Maibach, H. (2002) Exploration of alternative and natural drugs in dermatology. Arch. Dermatol. 138, 207-211.
15. Marciniak, J., Zalewska, A., Popko, J. and Zwierz, K. (2006) Optimization of an enzymatic method for the determination of lysosomal Nacetyl- beta-D-hexosaminidase and beta-glucuronidase in synovial fl uid. Clin. Chem. Lab. Med. 44, 933-937.
16. Matsubara, T., Aoki, N., Hino, S., Okajima, T., Nadano, D. and Matsuda, T. (2009) Serum and monoclonal immunoglobulin E antibodies from NC/Nga mice with severe atopic-like dermatitis recognize an auto-antigen, histone H3. Clin. Exp. Allergy 39, 579-590.
17. Matsumoto, M., Ra, C., Kawamoto, K., Sato, H., Itakura, A., Sawada, J., Ushio, H., Suto, H., Mitsuishi, K., Hikasa, Y. and Matsuda, H. (1999) IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J. Immunol. 162, 1056-1063.
18. Milgrom, H. (2002) Attainments in atop: special aspects of allergy and IgE. Adv. Pediatr. 49, 273-297.
19. Morita, Y., Matsumura, E., Okabe, T., Fukui, T., Ohe, T., Ishida, N. and Inamori, Y. (2004) Biological activity of beta-dolabrin, gamma-thujaplicin, and 4-acetyltropolone, hinokitiol-related compounds. Biol. Pharm. Bull. 27, 1666-1669.
20. Morita, Y., Matsumura, E., Okabe, T., Shibata, M., Sugiura, M., Ohe, T., Tsujibo, H., Ishida, N. and Inamori, Y. (2003) Biological activity of tropolone. Biol. Pharm. Bull. 26, 1487-1490.
21. Morita, Y., Matsumura, E., Tsujibo, H., Yasuda, M., Okabe, T., Sakagami, Y., Kumeda, Y., Ishida, N. and Inamor, Y. (2002) Biological activity of 4-acetyltropolone, the minor component of Thujopsis dolabrata SIeb. et Zucc. hondai MakBiol. Pharm. Bull. 25, 981-985.
22. Noshita, T., Ishiai, S., Furukido, T. and Funayama, S. (2009) Isolation of (-)-4'-demethyl traxillagenin from Thujopsis dolabrata Sieb. et Zucc. var. hondai Makino. J. Nat. Med. 63, 105-106.
23. Pariser, D. (2009) Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption. Am. J. Ther. 16, 264-273.
24. Qi, X. F., Kim, D. H., Yoon, Y. S., Li, J. H., Jin, D., Deung, Y. K. and Lee, K. J. (2009) Effects of Bambusae caulis in Liquamen on the development of atopic dermatitis-like skin lesions in hairless mice. J. Ethnopharmacol. 123, 195-200.
25. Saeki, H., Furue, M., Furukawa, F., Hide, M., Ohtsuki, M., Katayama, I., Sasaki, R., Suto, H. and Takehara, K. (2009) Guidelines for management of atopic dermatitis. J. Dermatol. 36, 563-577.
26. Takahashi, K., Nagahama, S., Nakashima, T. and Suenaga, H. (2001) Chemotaxonomy on the leaf constituents of Thujopsis dolabrata Sieb. et Zucc.-Analysis of neutral extracts (diterpene hydrocarbon). Biochem. Syst. Ecol. 29, 839-848.
27. Yamaji, K., Mori, S., Akiyama, M., Kato, A. and Nakashima, T. (2007) The antifungal compound totarol of Thujopsis dolabrata var. hondai seeds selects for fungi on seedling root surfaces. J. Chem. Ecol. 33, 2254-2265.